Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
eli lilly
2
×
fda
life sciences
national blog main
2
×
national top stories
abbvie
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alkermes
allergan
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
buprenorphine
cariprazine
ceo
clinical hold
clinical study
clinical trials
combination
commissioner
congress
crispr
crispr-cas9
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
editas medicine
ethics
What
medicine
2
×
alkermes
antipsychotic
benefits
big
bio
bosley's
bosley’s
bridge
bucks
cas
caveats
ceo
commonly
crime
crispr
departure
designed
drug
editas
effect
exit
favor
fda
gain
guiding
katrine
moves
offer
panel
personnel
prescribed
psyche
roundup
surprising
treatment
vote
week
weighs
weight
Language
unset
Current search:
medicine
×
" eli lilly "
×
" national blog main "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More